Filing Flows › SeaStar Medical Holding (ICU) › Q2 2026
SeaStar Medical Holding (ICU) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 12, 2026
SeaStar Medical Holding (ICU) reported revenue of $615K for the second quarter 2026 (Q2 2026), +82% from a year earlier and +24% from the quarter before. Operating margin was -616.4%, net loss $3.7M (606.5% of revenue).
SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $615K | +24% | +82% |
| Operating profit | −$3.8M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$3.0M | — | — |
What changed
Revenue was $615K in Q2 2026, up 82% year over year and up 24% from the previous quarter.
Gross margin was 91.2%, down 0.8 points from Q2 2025. Operating costs exceeded revenue by $3.8M, an operating margin of -616.4%. Operating expenses grew 111% against revenue growth of 82%. The fastest-growing cost line was Research & development (+143%). The quarter ended with a net loss of $3.7M, wider than the previous quarter's $3.5M loss.
Operating cash flow was −$3.0M. Working capital and other items added $736K.
Questions
What was SeaStar Medical Holding's revenue in the second quarter 2026?
SeaStar Medical Holding (ICU) reported revenue of $615K for the second quarter 2026 (Q2 2026), +82% from a year earlier and +24% from the quarter before.
Was SeaStar Medical Holding profitable in the second quarter 2026?
Operating loss was $3.8M (-616.4% of revenue) and net loss $3.7M.